Connect with us

Published

on

Peel away the facade of fabulousness and the life of even the most powerful style star is often far more fragile than it seems.

Take John Demsey, the former Executive Group President at the Este Lauder Companies. A three-decade Lauder stalwart, Demsey helped steer the company from a mid-sized privately-run family concern to a publicly-traded cosmetics giant worth, at its peak, over $100 billion.

Last winter, as his father lay gravely ill and his mother began battling cancer, the rest of Demsey’s world unexpectedly imploded. In early March 2022, Demsey was forced to retire from Lauder after he reposted an Instagram meme that contained the N-word.

Demsey insisted hed misinterpreted the meme, which was initially shared by the rapper Chingy.

Despite removing the post within hours, pressure from both Lauder employees and call-out accounts like Estee Laundry saw Demseys 31-year career at Lauder end in barely a week. Branded a racist and quieted as part of a legal agreement with his former employer Demsey had been canceled.  

It felt like Id been the victim of an identity theft, Demsey, 67, told The Post in an exclusive interview, his first since the Instagram fiasco 18 months earlier. I made a mistake and I corrected it. But the life I had before this happened simply does not exist anymore.

The mementos of that life cover nearly every surface of the six-story East Side townhouse, which Demsey, who’s divorced, bought in 2018 and shares with his 14-year-old daughter, Marie-Hlne, eight dogs, and a pair of cats.

Demsey has spent the majority of his post-Lauder existence here sometimes angry, sometimes depressed, often exercising (hes dropped 35 pounds), but mostly cooped-up and clearly contrite.

I almost feel like Ive been under house arrest, he deadpanned. And when I do go out, people act as if theyve sat shiva for me. 

In the multi-billion dollar world of luxury and beauty, few stars cast a wider shine than Demsey. Tall and imposing, the Stanford-educated exec was equally adept at creating buzz and making money.  

Demsey has always had a deep sense of what consumers want before they want it, said Professor Thomai Serdari, Director of the Fashion and Luxury MBA Program at New York University, of Demseys tenure at Lauder. He is very good at commercializing brands … while providing the glue that makes ventures work.

Demseys presence at Lauder was particularly potent in two areas: far-sighted advertising campaigns and his chairmanship of the MAC AIDS fund, which has raised $500 million for HIV research over the past 25 years. 

In the ad world, Demsey is best known for the decades of VivaGlam and Beauty Icon promotions he oversaw for MAC. Many of their stars were black RuPaul, Rihanna, Diana Ross, Missy Elliott, Nicki Minaj. And Demseys intimacy with African-American artistry provided him with a level of racial maneuverability rarely afforded to white execs.

Long before the era of George Floyd, John was one of the most culturally attuned people when it came to inclusivity, longtime former Wall Street Journal fashion reporter Teri Agins told The Post. John was accepted by black people because it always felt like he was in the culture. 

Dressed in a tan suit and Zegna sneakers, Demsey displayed both incredulousness and humility as he recounted the events of the past year. He freely described his actions on social media as stupid and impulsive a casualty of the near-manic Instagramming which overtook him during Covid.

I was posting like 20 or 30 times a day, he said. People really responded to it and it just became this sort of a thing. 

The Chingy meme, Demsey explained, appeared randomly in his feed a Covid-era Big Bird tending to a bed-ridden Snuffleupagus accompanied by the phrase My n***a Snuffy done got the rona at a Chingy concert.

Demsey insists he read n***a as nanna a nod to Snuffleupagus grandmotherly get-up.

Ive never used that word in my life, Demsey said of the racial slur hes accused of promoting.

Even though Chingy himself went on Instagram to defend him, no one else will ever really know what Demsey was thinking when he pushed that share button. 

Branded a Lauder liability and a poster boy for white privilege Demseys demise reflects both the punitiveness of this current cultural climate along with a misguided belief in his own indispensability. 

I was a bit of an impresario, he said. And those businesses and people that I supported were very successful because that’s the way I was.

Indeed, what does matter, say longtime Demsey admirers, is his track record of hiring African Americans.

Take Sean “Puffy” Combs, who Demsey brought to Este Lauder in 2004 back when other beauty groups were reluctant to sign the rapper for a fragrance deal. Barely a year later, Combs’ scent Unforgivable had achieved $1.5 million in sales per week, according to The New York Times. 

John is one of the good guys, said Richard Parsons, the former Time Warner and Citigroup CEO and Chair of the Apollo Theater Foundation on whose board Demsey served for a decade. As far back as the 90s he was a leader in putting people of color in magazines and photo shoots he made a difference. 

Years before DEI mandates became standard, Demsey was providing exposure and paychecks to many African-American singers, stylists, and makeup artists.

For someone whos contributed so much to black culture, to hip-hop culture to have his career end like this is disheartening in every way, said creative director June Ambrose, whose clients have included MAC campaign stars such as Missy Elliott and Mary J. Blige.

A white man who earned nearly $10 million in 2021, Demsey is certainly privileged. But just because youre privileged, Ambrose continued, doesnt mean youre racist.

Demsey concedes hes disappointed by the friends who failed to publicly support him after he left Lauder. Harder still was the loss of the Lauders themselves, whom he had considered an extended family.

“I loved the family, particularly [chairman emeritus] Leonard Lauder because I felt that their values were so contrary to what other companies were about,” Demsey said.

Agins, for one, never imagined the company would actually let Demsey go. Sure, John’s actions were sloppy, but I figured he would be suspended and then Lauder would move past it, she told The Post.  

Yet as the very public face of a very public company, Demsey stood little chance of surviving the scandal.

You cannot earn enough accolades to divorce yourself from racial sensitivity, says Ernest Owens, author of the book “The Case for Cancel Culture.” This is about impact not intent.

Still, Owens concedes that Demsey was impacted by the corporate house cleaning that followed the murder of George Floyd. Had this happened before summer 2020, [Demsey] might have had a very different outcome, he said.

Yet while Demsey was hardly the only style leader charged with racial insensitivity Vogue Editor-in-Chief Anna Wintour, for instance, issued a mea culpa for “publishing images or stories that have been hurtful or intolerant” during her career   he was one of the few to actually wind up unemployed. 

But with Este Lauder stock down nearly 50% since his departure, Demsey may have actually been more indispensable than the Lauders realized.

Indeed, two years after he brought Sean Combs to Lauder, Demsey also convinced the company to launch fragrance and beauty lines for Tom Ford. Last November, Lauder snapped up Ford’s fashion label for a cool $2.8 billion the company’s first foray into the apparel arena since it was established nearly 75 years ago. 

Demseys home is a dizzying assemblage of art, furniture, an especially photography. There are nearly 600 photos in total from historic prints by Henri Cartier-Bresson to outtakes from Demsey’s many MAC campaigns. 

Its from here that Demsey is readying his next acts. He has no other choice, he said.

I dont want to be known as the canceled guy  for my legacy to be defined by just three hours on social media. 

Still bound by his reported Lauder non-compete, Demsey has taken on a senior advisory role with L Catterton, the private equity group tied to LVMH chief Bernard Arnault, where he’ll help identify and grow new business opportunities. Although the headlines accompanying Demsey’s appointment made note of the Lauder saga, NYU’s Serdari believes the business world has moved past it.

“People make mistakes,” she said, “but that shouldn’t take away from his expertise and intellectual ability.”

There’s also “Behind the Blue Door,” a hefty coffee-table book detailing the museum-like treasures throughout his home, which he co-authored with “CBS Sunday Morning” contributor Alina Cho and is inspired by the vintage blue door fronting his townhouse. The book will be released on October 17th.

Demsey is also returning to the social swirl he once dominated. In June he hosted a birthday party for stylist and costume designer Ambrose at his home where folks like actor Zachary Quinto and Bergdorf Goodman exec Linda Fargo appeared to have moved on from the meme.

And, so has Demsey whose father ultimately passed away in June 2022, while he moved his mother from Ohio to New York in order to look after her. Im not done not at all, he said. Ive got a lot more in me, a lot more to say. The world is still a very exciting place. 

dkaufman@nypost.com

Continue Reading

Sports

Phillies clinch NL East with wild win vs. Dodgers

Published

on

By

Phillies clinch NL East with wild win vs. Dodgers

LOS ANGELES — Kyle Schwarber, Weston Wilson and Bryce Harper homered, and the Philadelphia Phillies clinched their second straight NL East title with a wild 6-5 victory over the Los Angeles Dodgers on Monday night.

It was the earliest division clinch in franchise history, two days sooner than the 2011 club that clinched on Sept. 17. The Phillies got it done in Game 151, second fastest in club history behind the 2011 Phillies who did it in Game 150.

The Phillies also notched a 90-win season for the third straight year for only the third time in franchise history.

Since the New York Mets were idle Monday, the Phillies needed a win to clinch the division. They blew leads of 1-0 and 4-3 before getting past the NL West-leading Dodgers for their ninth win in 11 games.

Since the July trade deadline, the Phillies are 29-14. They’ve held it together despite injuries to key players.

The Phillies lost right-hander Zack Wheeler when he went on the injured list a month ago because of a blood clot in his right shoulder. The club’s pitching depth has allowed it to absorb the loss because of its six-man rotation. Wheeler was 10-5 with a 2.71 ERA in 24 starts when he was sidelined.

Shortstop Trea Turner (right hamstring strain) and third baseman Alec Bohm (left shoulder inflammation) are both on the IL. Manager Rob Thomson said Bohm could return later this week at Arizona, and Turner could be back in time for the final homestand of the regular season.

The win made Thomson only the third manager in franchise history to win consecutive division titles, joining Charlie Manuel (2007-11) and Danny Ozark (1976-79). He’s only the fourth manager in major league history to reach the postseason in each of the first four full seasons of a managerial career. Among the other three is Dodgers manager Dave Roberts.

Continue Reading

Business

Britain’s drugs industry is suffering withdrawal symptoms, and it could prove costly

Published

on

By

Britain's drugs industry is suffering withdrawal symptoms, and it could prove costly

When it comes to the drugs industry, Britain is suffering withdrawal symptoms.

This year, three of the world’s biggest pharmaceutical companies – Merck, AstraZeneca, and Eli Lilly – have pulled or paused UK investments worth almost £2bn, diagnosing that market conditions, specifically the NHS drugs pricing regime, make the UK a “contagion risk”.

The issue will be highlighted this week as Donald Trump begins his state visit, with executives called to give evidence to a parliamentary select committee on Tuesday, along with science minister Lord Vallance, a veteran of the pandemic, when government worked closely with pharmaceutical companies to speed up vaccine development.

How has this come about?

The UK pharmaceutical industry is one of those caught in the crossfire of Trump’s trade war.

In the trade deal agreed by the president and Sir Keir Starmer in May, the prime minister committed to “improve the overall environment for pharmaceutical companies in the United Kingdom”.

Please use Chrome browser for a more accessible video player

What does the UK-US trade deal involve?

Four months later, those companies – under pressure from Trump to charge US consumers the same as those in Europe, and to invest in US production and research – say the opposite is the case.

They argue the British market is becoming unviable to pharmaceutical investors, at a cost to patients, jobs, and the economy.

Data from the Association of British Pharmaceutical Industries bear this out; R&D investment growth has fallen below the global average and foreign inward investment has declined almost 60% since 2020.

Why the corporate backlash?

To understand why an industry long regarded as a domestic strength has turned against the UK, it is necessary to understand the complexities of medicines pricing.

The NHS is one of the largest “single buyers” of medicines in the world, a position that has long given it clout when it comes to negotiating prices. In the last two decades, however, strict conditions on what drugs are approved for use, and at what price, have brought down the price of the medicines but eroded the value of the UK to the companies that provide them.

Simply put, the industry believes the NHS has been getting too good a deal for too long and argues the terms are no longer sustainable.

In the last decade, the proportion of the NHS budget spent on medicines has fallen to just 9%, below the EU average of 13%. Meanwhile, the amount of revenue returned by companies to the government under complex “clawback” arrangements has jumped to more than 23%, more than three times the EU average.

Under these complex rules, a form of price control that offers a uniform discount to the health service, manufacturers return revenue equal to the value of any overspend by the NHS on its total medicines budget.

The figure has risen rapidly in the UK in the last five years as the NHS has exceeded its medicines budget faster than it has risen. This year it was supposed to be 15%, already double the EU average, but has already risen to 23.5%.

Please use Chrome browser for a more accessible video player

Trump visit: Vanity trip or power play?

Can this all be resolved?

The industry is demanding a commitment to return to single figures by the end of this parliament. Emergency talks with the health department broke up in the summer, and it is unclear when they will resume.

It also wants the threshold at which new drugs are admitted to the NHS marketplace, currently £20,000-£30,000 and unchanged since 1999, increased. Had it risen in line with inflation, it would be £40,000-£60,000 today.

As a consequence of these downward pressures on price, the industry says the number of new and innovative medicines offered to patients has fallen, with only 37% of available drugs accessed by the NHS, compared to 90% in Germany.

Why so much is in the gift of the chancellor

Paying higher prices to hugely profitable pharmaceutical giants was not part of Labour’s electoral promises for the NHS, and Health Secretary Wes Streeting says he is committed to getting the best deal for patients, but the UK discount may no longer be sustainable.

The issue also highlights a tension between the government’s desire for economic growth and greater efficiency in its key public service.

As one executive put it, as the UK accounts for only 2.5% of the global medicines market, which meant for a long time the lower margins doing business in Britain could be swallowed. With Trump demanding price parity for the US, which accounts for 40%, that is no longer the case.

Read more from Sky News:
UK and US firms announce nuclear deals
PM urged to up pressure over Trump tariffs

Please use Chrome browser for a more accessible video player

Reeves announces date of the budget

Life sciences are at the heart of the government’s new industrial strategy and the UK still has much to commend it, with world-leading research and skills and a track record of spinning biotech innovation into the private sector. But the withdrawal of big pharma investment tells a different story.

Johan Kahlstrom, country president of Novartis UK and Ireland, said: “The UK is fast becoming uninvestable for life sciences companies.

“High clawback taxes that take almost a quarter of revenues, combined with outdated cost-effectiveness thresholds that haven’t changed in over 25 years, are eroding the UK’s position as a global life sciences hub.”

Resolving the pricing row will require compromise and money, with the health secretary’s room for manoeuvre ultimately resting on the Treasury, and the balance between losing jobs and investment from a growth industry, and a drugs budget the NHS has long taken for granted.

Continue Reading

US

Trump sues New York Times

Published

on

By

Trump sues New York Times

Donald Trump has announced he’s suing The New York Times, just days after he threatened to do so over its reporting into his ties to Jeffrey Epstein.

In a post on his Truth Social platform, the US president said he had “the Great Honor of bringing a $15bn Defamation and Libel Lawsuit” against “one of the worst and most degenerate newspapers in the History of our Country”.

Mr Trump’s lengthy post – made late on Monday – is focused on his belief the outlet is bias towards the Democrats, citing the endorsement of Kamala Harris in last year’s presidential election.

It has “been allowed to freely lie, smear, and defame me for far too long”, he added.

Read more from Sky News:
Trump sends National Guard into another city
The massive security operation for Trump’s visit

The lawsuit – which has been brought in Florida – comes after Mr Trump raised the prospect of suing the newspaper last week for publishing articles about alleged notes he had sent Epstein.

He dismissed the reporting as false.

A lewd birthday message Trump allegedly sent to the convicted sex offender for his 50th birthday in 2003 was published by the US Congress days later.

The pages are contained in files from the estate of the deceased billionaire paedophile, handed over to a Congressional committee.

The collection of birthday tributes include a hand-drawing of a woman’s body, signed “Donald”. They also contain a picture of Epstein holding an outsized cheque, signed by “DJTRUMP”.

Mr Trump has maintained the note wasn’t written by him, claiming the handwriting and signature do not match his own.

An alleged note written by Trump for Epstein. Pics: US Congress/NBC News
Image:
An alleged note written by Trump for Epstein. Pics: US Congress/NBC News

The “birthday book” also included notes from former British minister Peter Mandelson, who has been sacked as the UK’s ambassador to the US over revelations about his relationship with Epstein.

Mr Trump has repeatedly denied any impropriety involving Epstein, whom he once counted as a friend.

Please use Chrome browser for a more accessible video player

Handwriting expert analyses signature on Epstein card

Responding to his initial threat to sue, a spokeswoman for The New York Times said last week: “Our journalists reported the facts, provided the visual evidence and printed the president’s denial. It’s all there for the American people to see and to make up their own minds about.

“We will continue to pursue the facts without fear or favour and stand up for journalists’ First Amendment right to ask questions on behalf of the American people.”

Continue Reading

Trending